Further studies on the interaction between anthralin salicylic acid and zinc oxide in pastes.
D000873:Anthracenes / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D002384:Catalysis; D055598:Chemical Phenomena; D002621:Chemistry; D004338:Drug Combinations; D004347:Drug Interactions; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007202:Indicators and Reagents; D009824:Ointments; D010087:Oxides / Q000627:therapeutic use; D014677:Pharmaceutical Vehicles; D011565:Psoriasis / Q000188:drug therapy; D012459:Salicylates / Q000627:therapeutic use; D012996:Solutions; D012997:Solvents; D015032:Zinc / Q000627:therapeutic use
D000873:Anthracenes; D000891:Anti-Infective Agents, Local; D004338:Drug Combinations; D007202:Indicators and Reagents; D009824:Ointments; D010087:Oxides; D014677:Pharmaceutical Vehicles; D012459:Salicylates; D012996:Solutions; D012997:Solvents; D015032:Zinc